Dose intensity in advanced ovarian cancer: have we answered the question? - PubMed (original) (raw)
Affiliations
- PMID: 9816018
Review
Dose intensity in advanced ovarian cancer: have we answered the question?
D Fennelly. Clin Cancer Res. 1995 Jun.
No abstract available
Similar articles
- Role of carboplatin in ovarian cancer. Current results and thoughts for the future.
Ozols RF. Ozols RF. Acta Obstet Gynecol Scand Suppl. 1992;155:75-7. Acta Obstet Gynecol Scand Suppl. 1992. PMID: 1502894 Review. - [Carboplatin in cancer of the ovary].
Pujade-Lauraine E, Guastalla JP, Vincent P. Pujade-Lauraine E, et al. Bull Cancer. 2000 Aug;87 Spec No:40-7. Bull Cancer. 2000. PMID: 11082722 Review. French. - Platinum-based neoadjuvant chemotherapy for advanced ovarian cancer.
Markman M. Markman M. Gynecol Oncol. 2007 Jul;106(1):273-4; author reply 274-5. doi: 10.1016/j.ygyno.2007.03.013. Epub 2007 Apr 30. Gynecol Oncol. 2007. PMID: 17467780 No abstract available. - [First line chemotherapy for advanced ovarian cancer in 2000: standards and questions].
Cure H, Dauplat J, Cholet P. Cure H, et al. Bull Cancer. 2000 Feb;87(2):189-99. Bull Cancer. 2000. PMID: 10705290 Review. French. - [Dose intensity in chemotherapy of ovarian carcinoma: to what degree?].
Lopez M. Lopez M. Clin Ter. 1998 Nov-Dec;149(6):397-9. Clin Ter. 1998. PMID: 10100399 Italian. No abstract available.
Cited by
- Use of biotin targeted methotrexate-human serum albumin conjugated nanoparticles to enhance methotrexate antitumor efficacy.
Taheri A, Dinarvand R, Nouri FS, Khorramizadeh MR, Borougeni AT, Mansoori P, Atyabi F. Taheri A, et al. Int J Nanomedicine. 2011;6:1863-74. doi: 10.2147/IJN.S23949. Epub 2011 Sep 8. Int J Nanomedicine. 2011. PMID: 21931482 Free PMC article. - Chemopreventive effects of Peucedanum praeruptorum DUNN and its major constituents on SGC7901 gastric cancer cells.
Liang T, Yue W, Li Q. Liang T, et al. Molecules. 2010 Nov 9;15(11):8060-71. doi: 10.3390/molecules15118060. Molecules. 2010. PMID: 21063269 Free PMC article. - pHLIP-mediated translocation of membrane-impermeable molecules into cells.
Thévenin D, An M, Engelman DM. Thévenin D, et al. Chem Biol. 2009 Jul 31;16(7):754-62. doi: 10.1016/j.chembiol.2009.06.006. Chem Biol. 2009. PMID: 19635412 Free PMC article. - Canine parvovirus-like particles, a novel nanomaterial for tumor targeting.
Singh P, Destito G, Schneemann A, Manchester M. Singh P, et al. J Nanobiotechnology. 2006 Feb 13;4:2. doi: 10.1186/1477-3155-4-2. J Nanobiotechnology. 2006. PMID: 16476163 Free PMC article. - Tumor-specific targeting of an anticancer drug delivery system by LHRH peptide.
Dharap SS, Wang Y, Chandna P, Khandare JJ, Qiu B, Gunaseelan S, Sinko PJ, Stein S, Farmanfarmaian A, Minko T. Dharap SS, et al. Proc Natl Acad Sci U S A. 2005 Sep 6;102(36):12962-7. doi: 10.1073/pnas.0504274102. Epub 2005 Aug 25. Proc Natl Acad Sci U S A. 2005. PMID: 16123131 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical